New players and targets in tumour vasculature

ecancermedicalscience editor's choice for July and August 2014

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion

Melanoma live: Making patient-focused therapy decisions

ReDO project finds ways of repurposing generic drugs as beneficial cancer treatments

Repurposing generics to fight cancer and the work of the ReDO Project

Looking for biomarkers in metronomic chemotherapy

Metronomics and low/middle income countries, especially in breast cancer

Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies

Quality of life and cost advantages of metronomics and drug repurposing

Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer

Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative